PharVision Advisers »

Zymeworks Del shares owned by PharVision Advisers

Quarter-by-quarter ownership of Zymeworks Del (ZYME) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Zymeworks Del

Tip: Access up to 7 years of quarterly data

All positions including Zymeworks Del held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zymeworks Del by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $304k 18k 17.08

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Zymeworks Del

EcoR1 Capital
Rubric Capital Management
Morgan Stanley
BlackRock
BVF
Redmile Group
Vanguard Group
Perceptive Advisors
Vestal Point Capital
Ubs Global Asset Management Americas
Blackstone Group
Deutsche Bank Aktiengesellschaft
Assenagon Asset Management
Dimensional Fund Advisors
Nextech Invest

View all funds holding Zymeworks Del